|
KIF5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97390000017595E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08340000004592E-06 |
| Normal-vs-Stage2 |
3.76029999999972E-05 |
| Normal-vs-Stage3 |
7.833600E-04 |
| Normal-vs-Stage4 |
1.179410E-03 |
| Stage1-vs-Stage2 |
5.420800E-01 |
| Stage1-vs-Stage3 |
8.307200E-01 |
| Stage1-vs-Stage4 |
7.105200E-01 |
| Stage2-vs-Stage3 |
6.941400E-01 |
| Stage2-vs-Stage4 |
9.352800E-01 |
| Stage3-vs-Stage4 |
8.217400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.1560000047246E-08 |
| Normal-vs-AfricanAmerican |
2.590000E-04 |
| Normal-vs-Asian |
2.171700E-02 |
| Caucasian-vs-AfricanAmerican |
3.407600E-01 |
| Caucasian-vs-Asian |
7.931000E-01 |
| AfricanAmerican-vs-Asian |
9.415800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0982000026315E-08 |
| Normal-vs-Female |
3.511800E-02 |
| Male-vs-Female |
2.109700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62761999999983E-05 |
| Normal-vs-Extreme_Weight |
4.74799999317099E-09 |
| Normal-vs-Obese |
3.829600E-04 |
| Normal-vs-Extreme_Obese |
1.257330E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.618000E-01 |
| Normal_Weight-vs-Obese |
1.155050E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.816200E-01 |
| Extreme_Weight-vs-Obese |
2.289700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.255800E-01 |
| Obese-vs-Extreme_Obese |
4.133000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.023700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.171900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.33899999976705E-08 |
| Normal-vs-Age(81-100Yrs) |
2.41910000031709E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.252200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.385900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.781100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.700100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.848280E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.205570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.02820000003057E-06 |
| Normal-VS-Type2 PRCC |
1.3205000004568E-07 |
| Normal-VS-KIRP CIMP |
5.006500E-02 |
| Normal-VS-Unclassified PRCC |
2.800400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.248550E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.448400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.321800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.310800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.190560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.108000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.88540000068249E-08 |
| Normal-vs-N1 |
4.742800E-03 |
| Normal-vs-N2 |
1.142640E-03 |
| N0-vs-N1 |
1.614620E-01 |
| N0-vs-N2 |
7.229200E-01 |
| N1-vs-N2 |
3.231600E-01 |
|
|
